Proposed Relocation of Aventis' headquarters from Strasbourg to Paris
Since April 26, 2004, when Sanofi-Synthélabo and Aventis agreed to create sanofi-aventis, it has been confirmed that the headquarters of the new sanofi-aventis Group is to be located in Paris. Sanofi-aventis announced today that the Aventis site located in Schiltigheim will cease its activity during the course of next year. The business activity will be transfered to Paris. The French Works Council - " Comité d'Entreprise " - of the Schiltigheim site was informed about this proposed relocation during the meeting held today, November 25, 2004.
Aventis employs a staff of 220 in Schiltigheim, as well as 60 service providers. In accordance with the Group's employment policy, a series of measures intended to facilitate staff mobility will be implemented with the aim of redeploying all employees. Management has also expressed its intention of continuing to work together with all the scientific, economic and social bodies in the Alsace region, particularly in the area of Research, through its Research center in Strasbourg. In addition, in order to minimize the impact that this transfer of activities to the Paris area will have on local employment, the SOPRAN company, a wholly-owned subsidiary of the Group, has been instructed to look for new business activities favoring employment in the Alsace region.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
